tpst: the income statement

MyFinsight

Tempest Therapeutics, Inc. (TPST)

For the quarter ending 2025-06-30, TPST made $142K in revenue. -$7,870K in net income. Net profit margin of -5542.25%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	3,871
General and administrative	4,095
Loss from operations	-7,966
Interest income and other income (expense), net	142
Interest expense	46
Total other income (expense), net	96
Provision for income taxes	-
Net loss	-7,870

Net loss per share of common stock, rsus and pre-funded warrants, basic	-2.07
Net loss per share of common stock, rsus and pre-funded warrants, diluted	-2.07
Weighted-average shares of common stock, rsus and pre-funded warrants outstanding, basic	3,802,956
Weighted-average shares of common stock, rsus and pre-funded warrants outstanding, diluted	3,802,956

Unit: Thousand (K) dollars (except for numbers of shares and EPS)